Brokerages Expect Medidata Solutions Inc (MDSO) to Announce $0.39 Earnings Per Share

Equities analysts predict that Medidata Solutions Inc (NASDAQ:MDSO) will post earnings of $0.39 per share for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Medidata Solutions’ earnings. The highest EPS estimate is $0.42 and the lowest is $0.36. Medidata Solutions posted earnings per share of $0.43 in the same quarter last year, which would suggest a negative year-over-year growth rate of 9.3%. The company is expected to report its next quarterly earnings report on Tuesday, July 23rd.

On average, analysts expect that Medidata Solutions will report full-year earnings of $1.83 per share for the current year, with EPS estimates ranging from $1.77 to $1.88. For the next year, analysts anticipate that the firm will report earnings of $2.14 per share, with EPS estimates ranging from $2.00 to $2.27. Zacks’ EPS calculations are an average based on a survey of research firms that follow Medidata Solutions.

Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Tuesday, April 30th. The company reported $0.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.33. Medidata Solutions had a return on equity of 9.28% and a net margin of 7.99%. The business had revenue of $173.50 million during the quarter, compared to analyst estimates of $172.12 million. During the same quarter in the previous year, the firm earned $0.40 EPS. Medidata Solutions’s revenue was up 16.3% on a year-over-year basis.

A number of brokerages have weighed in on MDSO. Zacks Investment Research lowered Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Tuesday, April 16th. BidaskClub upgraded Medidata Solutions from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, March 20th. Guggenheim began coverage on Medidata Solutions in a research note on Wednesday, April 17th. They set a “buy” rating and a $92.00 price target for the company. Finally, Dougherty & Co downgraded Medidata Solutions from a “buy” rating to a “neutral” rating in a research note on Wednesday, May 1st. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $84.28.

Shares of NASDAQ:MDSO opened at $90.65 on Friday. Medidata Solutions has a fifty-two week low of $60.10 and a fifty-two week high of $98.60. The company has a quick ratio of 2.57, a current ratio of 2.57 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $5.66 billion, a price-to-earnings ratio of 94.43, a price-to-earnings-growth ratio of 8.25 and a beta of 1.42.

In related news, EVP Michael Pray sold 15,000 shares of the business’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $76.50, for a total transaction of $1,147,500.00. Following the completion of the transaction, the executive vice president now directly owns 77,134 shares in the company, valued at approximately $5,900,751. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Daniel Patrick Shannon sold 19,725 shares of the business’s stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $75.17, for a total value of $1,482,728.25. Following the transaction, the executive vice president now owns 70,497 shares of the company’s stock, valued at $5,299,259.49. The disclosure for this sale can be found here. Insiders own 4.70% of the company’s stock.

Large investors have recently made changes to their positions in the stock. Arcadia Investment Management Corp MI grew its stake in shares of Medidata Solutions by 1.1% during the 1st quarter. Arcadia Investment Management Corp MI now owns 56,141 shares of the company’s stock valued at $4,112,000 after acquiring an additional 600 shares during the period. Virginia Retirement Systems ET AL bought a new position in shares of Medidata Solutions during the 4th quarter valued at approximately $452,000. BlackRock Inc. grew its stake in shares of Medidata Solutions by 2.9% during the 4th quarter. BlackRock Inc. now owns 6,995,601 shares of the company’s stock valued at $471,644,000 after acquiring an additional 195,763 shares during the period. American International Group Inc. grew its stake in shares of Medidata Solutions by 1.9% during the 4th quarter. American International Group Inc. now owns 161,630 shares of the company’s stock valued at $10,897,000 after acquiring an additional 3,091 shares during the period. Finally, Janus Henderson Group PLC grew its stake in shares of Medidata Solutions by 6.0% during the 1st quarter. Janus Henderson Group PLC now owns 1,837,555 shares of the company’s stock valued at $134,583,000 after acquiring an additional 103,716 shares during the period.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Further Reading: What Is An Exchange-Traded Fund (ETF)?

Get a free copy of the Zacks research report on Medidata Solutions (MDSO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.